Avail Medical Europe Ltd IM

Avail Medical Europe Limited | Information Memorandum

Financial Information

7 PROFIT AND LOSS

7.1. The below table details the Company’s profit and loss account.

PROFIT AND LOSS (£)

YE19 Statutory

YE20 Statutory

YE21 Statutory

YE22 Projected

Turnover

344,032

306,932

365,782

404,678

Other Operating Income

-

14,607

-

53

Cost of Sales

(126,486)

(104,294)

(140,458)

(141,824)

Gross Profit

217,546

202,638

225,324

262,854

Gross Profit Margin

63%

66%

62%

65%

Administrative Expenses

(197,352)

(217,691)

(230,610)

(167,081)

EBIT

20,194

(15,053)

(5,286)

95,773

Depreciation

8,822

6,877

8,897

9,657

EBITDA

29,016

(8,176)

3,611

105,430

Loans Written Off

-

25,053

-

-

Director's Salary

88,333

99,578

125,659

48,483

Adjusted EBITDA

117,349

116,455

129,270

153,913

12